Packages (Simulation)
Image (II)
-
SDS-PAGE Image
Quality Guarantee
Instruction Manual
Certificate
OVA Conjugated Orosomucoid 2 (ORM2)
AGP-B; AGP2; Alpha-1-Acid Glycoprotein Type 2
- Product No.CPB780Hu21
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- SourceProtein Conjugation
- Original Molecular Massn/a
- Buffer FormulationPBS, pH7.4.
- Traits Freeze-dried powder
- Purity> 90%
- Isoelectric Pointn/a
-
Applications
Immunogen; SDS-PAGE; WB.
If bio-activity of the protein is needed, please check active protein. - DownloadInstruction Manual
- UOM 10µg50µg 200µg 1mg 5mg
- FOB
US$ 120
US$ 300
US$ 600
US$ 1800
US$ 4500
For more details, please contact local distributors!
FORMULA
USAGE
Reconstitute in PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
STORAGE
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
GIVEAWAYS
INCREMENT SERVICES
| Magazine | Citations |
| Clin Exp Nephrol | Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome PubMed: 26351173 |
| Free Patents online | RHEUMATOID ARTHRITIS RELATED BIOMARKER 20170350884 |
| Osteoarthritis and Cartilage | Orosomucoid 2 serves for predicting but not for monitoring drug response in patients with knee osteoarthritis treated with chondroitin sulfate/glucosamine … 10.1016:j.joca.2018.02.412 |
| Therapeutic Advances in Chronic Disease | Predictive modeling of therapeutic response to chondroitin sulfate/glucosamine hydrochloride in knee osteoarthritis |
| Journal of Cosmetic Dermatology | Evaluation of serum and urinary orsomucoid protein A in psoriatic patients and their relation to severity of disease 33905172 |